Health care focused on people who live with 'T. cruzi' infection-Chagas disease
- Dates
- 12 March, 2020
- Location
- Paranimf, Faculty of Medicine, UB (Casanova, 143 - Barcelona)
- Tuition
- 100 € (students 70€) (on-site 130 €)
- Timetable
- 08.30 - 18.30 h
- Mode
- Face-to-face
- Language
- Spanish (simultaneous translation not provided)
- Length
- 1 day
- Credits
- 0,9 (file 09/027099-MD)
Due to the current situation with the SARS-CoV2 coronavirus, the 16h Workshop on Chagas Disease that had to take place in March 12 has been cancelled. It will be held on 2021.
In accordance with the data of the World Health Organisation (WHO), the Chagas disease is one of the 17 neglected and forgotten illnesses of the planet. 6 million people suffer from it and there are near 35,800 new cases every year. More than 7,000 people die annually because of this illness. Nevertheless the Chagas disease is still a neglected illness both in the endemic countries and those regions where it is considered an emergent illness, such as the United States, Japan or Australia.
In order to tackle this disease and update and share the latest scientific knowledge on it, we are pleased to announce that the 16th Workshop on Chagas disease will take place on March 12th, 2020 at the Faculty of Medicine of the University of Barcelona. This edition is entitled "Health care focused on people who live with T. cruzi infection-Chagas disease". You will find the schedule, deadline for abstract presentation (January 22th, 2020), and registration procedure, below or on the right side of this page.
Who Should Attend
Health, social and laboratory professionals.
Language
Spanish (simultaneous translation not provided)
Organization
Scientific Committee: Joaquim Gascon, Mª Jesús Pinazo, Janine Ramsey, Marcelo Abril, Colin Forsyth, Faustino Torrico, Javier Sancho, Cristina Ballart.
Organising Committee: Julio Alonso-Padilla, Ivette Fernández, Montserrat Gállego, Joaquim Gascon, Jordi Gómez, Irene Losada, Leonardo de la Torre, Mª Jesús Pinazo, Ethel Sequeira, Elizabeth Posada, Maira Carolina Guzamán Solano.
Activity of Health Care Interest
This workshop is officially recognised as an activity of health care interest by the Catalan Council for Continuing Medical Education (09/023878-MD) with 0.9 credits.
More Information
The deadline for the online registration is 6 March. Should you register on site, on the same day of the workshop, you will have to make a one-time payment, in cash, of 130 € (both student and normal single fare). The online payment can be done with Visa, MasterCard and American Express.
To get further information you can send us an email to the following adress: tallerchagas@isglobal.org
We collect and process your personal data for the sole purpose of responding to your information request. Your data will be used solely by the persons or teams in ISGlobal who require access to it to carry out their work and it will never, under any circumstances, be made available to third parties or transferred to third countries or international organisations.
We can only process your personal data with your consent, and it will be retained only as long as you do not withdraw consent.
You can exercise all your rights under current data protection regulations, including the right to access, correction, objection, erasure, portability and restriction, by writing to the Data Protection Officer (lopd@isglobal.org), attaching a copy of your national identity document or equivalent.
You have the right to withdraw your consent at any time. Withdrawal of consent does not affect the lawfulness of processing based on consent before its withdrawal. If you do not agree with the manner in which ISGlobal handles your data or you consider that your rights have been infringed, you can file a complaint at any time with the Spanish Data Protection Agency.
08.30—9.00 h. Reception and accreditation
09.00—9.15 h. Opening
Speakers: Pere Albajar Viñas (WHO), Carmen Castiella (AECID), Joaquim Gascon (ISGlobal)
09.15—9.45 h. Opening lecture: Conceptual framework of the people-centered care
Speaker: Pere Albajar Viñas (Responsible for the Chagas Programme, WHO Department of Control of Neglected Tropical Diseases)
09.45—10.15 h. Information, education and communication strategies as a starting point for a comprehensive care package for the Chagas disease in Ecuador
Speaker: Mariella Anselmi (Centro de Epidemiología Comunitaria y Medicina Tropical)
10.15—10.45 h. Coffee break
10.45—11.15 h. Oral communications
11.15—11.45 h. Diagnostic tools for field (LAMP/RDTs) and use in different scenarios for the Chagas disease
Speaker: Alejandro Schijman (INGEBI / CONICET)
11.45—12.15 h. Experience in indications and follow-up of the treatment: school for patients in Fiocruz Rio (Brazil)
Speaker: Tania Araujo (Fiocruz)
12.15—12.30 h. Poster presentations
12.30—12.45 h. Results of the Fexi-12 Study
Speaker: Fabiana Barreira (DNDi)
12:45—13.45 h. Discussion panel of key stakeholders in community and global mobilization
Organized by the Global Chagas Disease Coallition
Moderator: Javier Sancho Mas
13.45—14.45 h. Lunch
14.45—15.15 h. Design of access strategies to healthcare services in an endemic country
Speakers: Ana Pereiro (Mundo Sano Foundation)
15.15—16.45 h. Working groups:
Group 1. Workshop on access: "Refocusing the attention on people with Chagas disease"
Moderators: Miriam Navarro (Universidad Miguel Hernández, Elche) / Elena Trigo (Hospital La Paz-Carlos III)
Group 2. Workshop on diagnosis: "Implementation assessment of PCR techniques and serology in different scenarios"
Moderator: Carmen Muñoz (Hospital de la Santa Creu i Sant Pau) / Alejandro Schijman (INGEBI / CONICET)
16.45—17.15 h. Oral communications
17.15—17.45 h. Conclusions of the working groups
17.45—18.30 h. Closing: 10 Years of the Chagas Bolivia-Barcelona Platform (ISGlobal-CEADES-AECID)
—
Celebration 10 Years Chagas Platform
Projects
See Past Projects
Clinical trial of new drug for chronic Chagas disease
Phase II multicenter, randomized, placebo-controlled study of the safety and efficacy of three oral dosing regimens of E1224 and benznidazole in adult patients with chronic indeterminate Chagas disease